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Abstract
Background: Molecular assays targeted to nucleic acid (NA) markers are becoming increasingly important to medical
diagnostics. However, these are typically confined to wealthy, developed countries; or, to the national reference laboratories
of developing-world countries. There are many infectious diseases that are endemic in low-resource settings (LRS) where
the lack of simple, instrument-free, NA diagnostic tests is a critical barrier to timely treatment. One of the primary barriers to
the practicality and availability of NA assays in LRS has been the complexity and power requirements of polymerase chain
reaction (PCR) instrumentation (another is sample preparation).
Methodology/Principal Findings: In this article, we investigate the hypothesis that an electricity-free heater based on
exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA
amplification assays. We assess the heater’s equivalence to commercially available PCR instruments through the
characterization of the temperature profiles produced, and a minimal method comparison. Versions of the prototype for
several different isothermal techniques are presented.
Conclusions/Significance: We demonstrate that an electricity-free heater based on exothermic chemical reactions and
engineered phase change materials can successfully incubate isothermal NA amplification assays, and that the results of
those assays are not significantly different from ones incubated in parallel in commercially available PCR instruments. These
results clearly suggest the potential of the non-instrumented nucleic acid amplification (NINA) heater for molecular
diagnostics in LRS. When combined with other innovations in development that eliminate power requirements for sample
preparation, cold reagent storage, and readout, the NINA heater will comprise part of a kit that should enable electricity-free
NA testing for many important analytes.
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Introduction
Clinical diagnostic assays targeted to nucleic acid (NA) markers
are becoming an increasingly important part of the clinician’s
toolbox. Many disease states are difficult to diagnose due to the
lack of specific and well-characterized biomarkers in an accessible
specimen. These generalizations apply in particular to infectious
disease diagnostics. The clinical signs of infection are often non-
specific (e.g., inflammation or fever) and may originate from many
possible sources, yet the treatments are more often specific and
require an accurate diagnosis to be effective. There are many
infectious diseases endemic in LRS where the lack of simple,
instrument-free, NA diagnostic tests is a critical barrier to effective
treatment, in part because of co-morbidities that confound a
differential diagnosis. These diseases include malaria, human
immunodeficiency virus (HIV-1), tuberculosis (TB), influenza, and
many others.[1] Millions of lives are lost and a huge morbidity
burden incurred through inadequate diagnosis and treatment of
these diseases.[1] In many cases the need for rapid diagnostics
appropriate for these LRS is so severe that mediocre performance
tests such as RDT are preferred to less accessible but better
performing NA tests.[2] Clearly, any technology that can increase
the practicality and availability of NA assays in LRS could have a
significant impact on global public health.
Nucleic acid detection, to date, has mainly been confined to
wealthy, developed countries or to the large centralized facilities in
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19738the developing world that can marshal the resources required to
perform these techniques. Like many molecular diagnostic assays,
nucleic acid amplification techniques (NAATs) typically require a
significant investment in equipment, training, and infrastructure.
Economic and infrastructural realities dictate that diagnostics for
the developing world need to be foremost inexpensive; but also,
accurate, reliable, rugged, and suited to the contexts of these low-
resource settings (LRS).[3–5] Recent guidelines published by the
World Health Organization recommend that diagnostic devices
for developing countries should be ASSURED: Affordable,
Sensitive, Specific, User-friendly, Rapid and robust, Equipment-
free, and Deliverable to end users.[6] In some diagnostic contexts
in LRS, rapid diagnostic tests (RDT) based on the immunochro-
matography strip (ICS) fit the ASSURED model, albeit with
limited sensitivity and specificity.[7–9] NAAT assays that use
polymerase chain reaction (PCR) amplification are capable of
providing excellent sensitivity and specificity but generally fail to
meet the ASSURED guidelines for affordability, rapidity and
robustness, equipment-free operation, and deliverability.[10,11]
Appropriate, low-cost, equipment-free, pathogen-specific NA
marker assays that characterize medical care in much of the
developing world remain unavailable in LRS.
One of the primary barriers to the practicality and availability of
NA assays in LRS has been the complexity of PCR amplification.
PCR is inherently impractical in LRS where reliable electrical
power, complex equipment, training, reagent storage, quality
programs and clean water, are intermittent or absent. [1,12]
Recently, there have been significant developments in a class of
NAATs that do not require temperature cycling.[13–16] A
comprehensive review of these techniques, and their application
in LRS has recently been published. [17] These isothermal
amplification techniques vary in amplification temperature and
duration, as well as complexity of reagents required—and many
are proprietary—but all have the potential to be simpler and
require less complex equipment than PCR-based assays. These
methods use a variety of reaction principles to specifically amplify
NA targets through isothermal melting, exponential amplification
and intermediate target generation; and which, in several cases,
can be detected directly without the need for an instrument.[17–
20] Nevertheless, almost all investigators and manufacturers
currently use some type of electrically powered equipment to
achieve and maintain the temperature required for amplification,
although this equipment can be much simpler than the typical
PCR thermocycler. This inherent simplicity makes isothermal
amplification more appropriate for diagnostics in LRS.
One of the letters in the acronym ASSURED — the guideline
for providing diagnostics to LRS — represents ‘‘equipment free.’’
We are currently developing a non-instrumented nucleic acid
(NINA) platform that requires no detection instrument, no
electrical power, no batteries, and no external reagents. We
believe this can be achieved by combining isothermal amplifica-
tion with a novel method for generating the required temperature
profile without electrical power in a simple disposable that
contains the lyophilized assay reagents. Our first prototype of this
platform uses loop-mediated amplification (LAMP) [21] as the
model for an isothermal amplification technique and malaria as a
model diagnostic target. The amplification protocol requires
incubating the reaction mixture at ,65uC for at least 60 minutes.
This temperature requirement is sufficiently flexible that small
excursions (+/21.5uC) around this target are tolerable. [22–26]
LAMP (and several other isothermal techniques) have been shown
to far less sensitive to inhibitors than PCR, to the point where
direct assay of whole blood and other unpurified specimens is
feasible.[18,19] In those cases, no power or instruments are
required for NA purification, as is the case with PCR. In addition,
recent advances in protein stabilization make it likely that the
reagents can be dried-down in the reaction tubes with sufficient
stability to avoid the need for a cold-chain during delivery and
storage. Thus, another power consuming ‘‘instrument’’ is
eliminated. We have not yet attempted to package all of these
features and advances into a single prototype device; however, the
successful demonstration of electricity-free temperature-controlled
heating in a disposable format reported here is an important first
step toward the long-term goal.
The prototype NINA platform exploits exothermic chemical
heating, as used in ‘‘ready-to-eat’’ meals and camping hand
warmers. Table S1summarizes the prior history of prototype
development. Hatano and coworkers recently described a crude
heater that was able to perform a qualitative LAMP assay for
anthrax using off-the shelf pocket hand warmers and a Styrofoam
box. [27] Dominguez et al. used a similar container with an
unspecified phase change material to maintain a stable incubation
temperature for a commercial interferon gamma release assay at
37C (although the heat source was conventional). [28] While these
interesting approaches are compelling in their simplicity, the bulky
apparatus displayed slow warm-up (.30 min.); and for LAMP,
significant temperature variation within incubation time, and a
lack of run-to-run repeatability was observed. To meet the
performance goals implied in the ASSURED guidelines, an
optimized heating unit should be engineered to eliminate or
minimize all sources of variation. When combined with the
temperature-moderating characteristics of engineered phase
change materials (EPCM), we demonstrate that an engineered
exothermal chemical heating unit can produce a consistent
constant-temperature incubator for isothermal NA amplification
suitable for a variety of isothermal techniques.
Results and Discussion
Heat Production and Temperature in the NINA Heater
Ten replicate runs of the optimized prototype displayed
minimal variation in temperature from run to run within the
reaction tubes (Figure 1). The heater reached the optimal
incubation temperature in 15 minutes, and maintained the target
temperature with minimal drift over 60 minutes. (Drift from
minimum to maximum temperature within run, mean over all
runs =2uC.) Comparison of the temperature plots for the CaO,
EPCM, and reaction tubes in Figure 1 to Figure 1B in Hatano et
al.[27] illustrates the beneficial effect of having the EPCM
component in the heater. The CaO temperature traces show
rapid and poorly controlled heat generation, with maximum
temperatures exceeding 100uC. The traces of the EPCM at the
interface with the CaO have a pattern similar to the CaO, but the
initial temperature excursions are reduced in magnitude, and the
plots are far more repeatable. Finally, the reaction tubes display
only a uniform ramping to the target temperature followed by a
prolonged stable isothermal phase. The temperature in the NINA
reaction appears more uniform than that shown by Hatano et
al.[27] for their hand-warmer device.
These results evince the potential of EPCM in an optimized
design for controlling exothermic reactions in a simple NINA.
This level of temperature control is important to enable
conformance to the ‘‘sensitive’’, ‘‘specific’’, and ‘‘robust’’ aspects
of the ASSURED guidelines. Once the abundant heat from the
CaO reaction begins to melt the EPCM, the additional heat
produced by the exothermic reaction is converted into the latent
heat of fusion of the EPCM. Thus, the temperature in the EPCM
remains constant at the selected melting temperature until the
Nucleic Acid Amplification without Electricity
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the EPCM is rapid). Once the CaO reaction has reached
equilibrium, the energy stored as latent heat keeps the two-phase
EPCM at the target temperature until complete solidification.
In our optimization work we observed that the purity of the
CaO need not be high, although it should be consistent to yield
consistent heat profiles (data not shown). The ability to use less
pure CaO is important for minimizing the cost per amplification,
addressing the ‘‘affordable’’ aspect of the ASSURED guidelines.
Other key physicochemical parameters of raw CaO (particle size,
particle porosity, presence of unoxidized calcium carbonate ‘‘grit’’,
etc.) that result from variation in kiln calcination of limestone[29]
(the industrial manufacturing process) also must be kept consistent
for consistent heat profiles. However, we were able to produce
precise heat profiles in our prototypes with commodity grades of
CaO. This makes the only disposable materials (CaO, water, and
PCR tubes) in the device very inexpensive. The reaction of CaO
and water can be tuned somewhat to control the steepness of the
temperature ramp and the maximum temperature for a given
reaction chamber, although flexibility and precision is greatly
improved by including the EPCM.
The EPCM used here is tunable for many of its important
characteristics (melting temperature range, specific heat capacity,
thermal conductivity, etc.) making this device a flexible incubation
platform potentially applicable to a number of isothermal
amplification techniques. When evaluated by differential scanning
calorimetry, the EPCM melts over a range of temperatures around
the target (62uC), and displays some hysteresis in the phase
change, presumably due to polydispersity in polymer chain length
and supercooling of the EPCM (personal communication from
Renewable Alternatives). It is unclear at this time how this
behavior contributes to variation seen in the results of the LAMP
assay; however, the manufacturer of the EPCM is confident that
further development of the EPCM for this application will mitigate
this behavior. The EPCM is a fully hydrogenated fat product, so it
is resistant to environmental oxidation and should be very stable.
While the EPCM is not currently as readily available as CaO, and
is not a commodity product like CaO, similar materials have been
used in consumer products in the US. These EPCMs are made
mainly from bio-based fats — namely beef tallow, palm oil,
coconut oil and soybean oil — so local, low-cost production of the
EPCM in the developing world should be feasible.
Portable energy for heat production could, of course, be
supplied with conventional batteries, so a comparison seems
appropriate. A cost analysis indicates that on a per calorie per test
basis, using CaO as a thermal battery is several times less
expensive than mass-produced, disposable, dry-cell batteries. Costs
are scaled by the projected number of analytical runs possible and
include both energy source and control hardware. CaO
disposables are single use, while dry cells are expected to last five
runs based on their energy density (four D-cells would be
required). Two grades of CaO (reagent grade and soap grade),
with an EPCM are compared to three possible dry-cell
implementations (with an EPCM, with microprocessor closed-
loop control, with thermostat closed-loop control). With a
projected cost per run of US$0.56, the soap-grade CaO/EPCM
combination is clearly the least-expensive alternative (compared to
$1.40, $1.17, $1.21, and $1.16 for reagent-grade CaO/EPCM, D-
cell/EPCM, D-cell/microprocessor, and D-cell/thermostat, re-
spectively.) Costs were estimated from MSRP. Increased value
of CaO over the alternatives could be realized at increased
production volumes. Any special disposal or recycling required
does not seem any more onerous than what is required for
common batteries.
The data shown here were not gathered under any stringent
external environmental control; therefore, given that testing was
performed in an air-conditioned laboratory, it is likely that the
system was not challenged in the same way as it would be at its
intended point of use. The wide external temperature ranges
found in LRS could significantly change the ramp time and/or
duration at the desired temperature of the heater, possibly
significantly, but the characteristics of the EPCM will ensure that
the desired temperature is held for some period of time, regardless
– without calibration to the ambient conditions or closed-loop control. First
principles of heat transfer dictate that the effects of ambient on
ramp time and/or duration should be greatest when the desired
temperature is furthest from ambient. Thus, the problem should
be appropriately non-dimensionalized to identify states of
similitude. We plan to explore these phenomena and to evaluate
their effects once we have improved our understanding of the
intrinsic variation in the assay chemistry sufficiently to evaluate
those effects. This evaluation will include trials under actual field
conditions.
LAMP Assay Demonstration and Comparison to a
Reference Heater
Representative images of the qualitative results (Figure 2) shows
1) the NINA heater is capable of supporting LAMP, 2) that
samples incubated in the NINA heater give results that are
virtually identical to those incubated in parallel in the GeneAmpH
9600. For both incubators the turbidimetric readout method
(Figure 2A) is difficult to interpret, but turbidity due to
accumulating LAMP product is observed (relative to the no-
template control, or NTC). The fluorescence of the Calcein
reagent when illuminated with a UV lamp (Figure 2B) is more
easily seen as an increase in intensity (relative to NTC) for the
dilutions that are .1 pg/mL. Note that there is some background
Figure 1. Temperature monitoring of the prototype designed
for ,656C LAMP assays. Note the repeatability of results at three
different locations over 10 replicate runs. (---) = target temperature
(63uC). Red = Temperature of the CaO, Green = Temperature at the
CaO/EPCM interface, Blue = Temperature of the amplification reaction.
Sampling frequency =1 Hz.
doi:10.1371/journal.pone.0019738.g001
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observations conform to those noted by the operator at the actual
time of the analysis, so no artifacts have been introduced by the
photographic process.
A quantitative comparison of Calcein fluorescence corroborates
the qualitative study. A statistical method comparison by the two
most common techniques indicates substantial quantitative
agreement between samples incubated in the NINA heater to
those incubated in parallel in the ESE-Quant Tube Scanner.
Linear regression of the fluorescence intensity units (FIU) observed
for samples incubated in the NINA heater as a dependant variable
of the FIU observed for samples incubated in the ESE-Quant
(Figure 3A) results in a slope of 0.98 and a y-intercept of 37.5 FIU,
with a coefficient of determination of 0.87. Bland-Altman analysis
(Figure 3B) reveals a mean difference (ESE – NINA) of 226 FIU,
no dependence of difference on mean, and all differences lie within
the 62s interval that indicates the differences are random, not
systematic. Although these experiments were intended to quickly
assess the agreement between heater types and were not designed
to rigorously define the dose response relationship of a nascent
assay, closer inspection of the FIU for each concentration (Figure
3A) reveals a general increase in response with increasing dose,
within the experimental noise limits of this admittedly small
sample set. As with the qualitative assay demonstration, consid-
erable background fluorescence was observed in NTC reactions in
both heaters (Figure 3A and 3B).
These results clearly show that the NINA heater can incubate
isothermal reactions predictably and precisely with no electricity
and without any form of closed-loop control. We also demonstrate
that it can be used for LAMP assays, with no discernable
difference when compared to two reference heaters, the
GeneAmpH 9600 and the ESE-Quant Tube Scanner. There is a
bias between the NINA heater and the ESE-Quant (NINA
higher), but this is not a significant finding considering we are
comparing FIU without any assay calibration. This bias would be
easily removed by applying a standard curve. Although we did not
intend to rigorously qualify the LAMP assay for malaria here,
these results suggest that a quantitative assay with a clinically
significant lower limit of detection and three decade dynamic
range might be possible with further development of the protocol.
Planned work will comprehensively compare incubation of several
isothermal assays with the NINA heater to incubation with
conventional, electrically-powered instruments by many metrics –
sensitivity, specificity, accuracy, precision, and other standard
figures of merit must all be assessed before equivalence can be
rigorously inferred. However, these prelimary results are very
encouraging.
Other Isothermal Techniques
We have also explored heaters with temperature profiles suitable for
other isothermal amplification techniques requiring different incuba-
tion temperatures, e.g., the Exponential Amplification Reaction
(EXPAR), Nicking Enzyme Amplification Reaction (NEAR), or
Recombinase Polymerase Amplification (RPA), could be integrated
with this method. These prototypes are not significantly different in
form, but use different EPCMs, and in one case a different exotherm.
A CaO heater with a different EPCM formulation has been shown to
yield a temperature profile suitable for EXPAR with a nominal
temperature of 55uC (Figure 4A). Evaluation with EXPAR reactions
are in process. We have also explored a similar heater approach with
sodium acetate (NaAc, Figure 4B). Hand warmers based on the
crystallization reaction of NaAc are common. In a purified form, at
typical ambient temperatures, liquid NaAc is thermodynamically
unstable but kinetically stable due to the absence of nucleating sites for
crystal formation. The application of a mechanical shock initiates the
exothermic crystallization, and when mixed as a 25% aqueous
solution the phase change occurs repeatably at ,37uC. In this system,
NaAc acts as both the exothermic reactant and the EPCM. This
system has the advantage of being regenerable (immersion of the
NaAc in boiling water is sufficient). For isothermal amplification
methods operating at temperatures below 45uC as well as for other
diagnostic applications requiring heating (e.g., smart-polymer-based
Figure 2. LAMP with qualitative visual readouts performed in both the NINA heater and a reference instrument. LAMP assays were
performed for a dilution series of P. falciparum genomic DNA (see figure for concentrations) with qualitative visual readouts and with amplification
performed in both the NINA heater and a reference instrument (Perkin Elmer GeneAmp Thermocycler 9600, set at 63uC). NTC= no template control.
A) A turbidimetric readout based on the scattering of accumulated magnesium pyrophosphate precipitate (a by-product of the amplification
reaction).[37] B) A fluorescence readout based on the Loopamp Calcein reagent. Pyrophosphate (a by-product of the amplification reaction)
competitively displaces the Calcein fluorophore from manganous ions (Mn++), relieving the quenching effect of the Mn++. Further fluorescent
enhancement results from the binding of magnesium ions (Mg++) by Calcein at the site vacated by Mn++.[30]
doi:10.1371/journal.pone.0019738.g002
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phase change system. These results establish that the heater is a
flexible platform for a number of isothermal detection techniques.
Assay Specific Limitations of This Investigation
We have shown results for an instrument-free LAMP assay with
a simple qualitative visual readout. As operated here, LAMP is an
exponential rate assay being assessed with an endpoint measure-
ment. Thus, the timing of reaction interrogation and/or a relia-
ble ‘‘stop’’ reaction are required for quantitative precision. If
quantitative results are required, improvements to the entire assay
system to facilitate precise timing will be necessary. This could
include, for example, a different heater-lid or incubation-vessels to
facilitate access, or a ‘‘reading window’’ in the heater to enable
Figure 3. Quantitative method comparison of LAMP performed in both the NINA heater and a reference instrument. LAMP assays
were performed for a dilution series of P. falciparum genomic DNA (see figure for concentrations), with amplification performed in both the NINA
heater and a reference instrument (ESE-Quant Tube Scanner, set at 63uC) for the same amount of time. Fluorescence intensity of the Calcein dye was
then read on the SpectraMax M2 plate reader with lex=485 nm and lem=515 nm. A) Linear regression analysis of the method comparison. The error
bars represent 62 s using the best unbiased estimate for replicate noise available from the data set. B) Bland-Altman analysis of the same data.
doi:10.1371/journal.pone.0019738.g003
Figure 4. Temperature monitoring of prototypes designed for other contexts. A) A representative plot for a CaO prototype with a
temperature set point of 55uC, suitable for EXPAR assays. B) Ten replicate plots of the NaAc prototype with a temperature set point of 38uC, suitable
for a variety of uses. As yet, this prototype has not been exhaustively optimized for precision as have the CaO/EPCM based units. Red = Temperature
of the CaO, Blue = Temperature of the amplification reaction. ( --- ) = target temperature. Sampling frequency =1 Hz.
doi:10.1371/journal.pone.0019738.g004
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elevated temperature ‘‘stop’’ (.80uC) is generally used for LAMP.
In our experimental work here, we used an electrical heat block for
this purpose; however, this could be accomplished with the
electricity-free heater by the inclusion of a parallel heating unit at a
higher temperature (essentially, by including a second incubation
chamber that uses a different EPCM, or no EPCM at all).
Alternatively, a chemical ‘‘stop’’ could be developed, or a boiling
water bath could be kept at hand. Other assays perform best with
a pre-amplification, high-temperature denaturation step (‘‘hot
start’’). A second incubator chamber could facilitate this feature
even more readily.
These data were gathered on contrived samples diluted in
buffer. It has already been demonstrated that LAMP assays can be
performed on clinically relevant specimens without NA extrac-
tion/purification and without a pre-amplification, high-tempera-
ture denaturation step.[31–35] Recent results of an HIV assay on
the NINA platform with clinical samples from HIV-positive
infants will be reported elsewhere.
Furthermore, neither turbidity nor Calcein reactions are
sequence-specific signals—as a result non-specific amplification
will also produce a strong signal—a possible cause of the NTC
background fluorescence noted above. Greater analyte specificity
should be possible by incorporating a fluorescent molecular
beacon probe specific to an internal region of the target amplicon,
thus minimizing non-specific signal. [28] Alternatively, the
amplified product could be the input to a lateral flow strip test
with a visual readout. [36–39]
Any of these potential improvements should be approached
with a secondary aim of minimizing the potential for amplicon
contamination from previous tests. Wherever possible, opening of
the amplicon container after amplification should be avoided. This
may be challenging if molecular beacon quenchers need to be
added, or aliquots for ICS testing need to be removed. Regardless
of how the system and assays are improved, we have clearly
demonstrated that the NINA heater is an effective device that can
facilitate the electricity-free amplification of NA using an
isothermal technique.
Future Directions
There are several applications of this technology that could have
an impact on diagnostics for LRS. One application is as a modular
amplification unit where a sample and the required reagents
would be introduced to the heater and amplified product
withdrawn for subsequent analysis by any simple detector. In this
embodiment a standard PCR tube can be the reaction chamber
and could be used later as a cuvette for fluorometric analysis to
resolve the presence of amplicons. This would free the user from
the high power requirements of electrical heating but would still
require some sort of detection instrument or device with its
attendant requirements. One could also imagine how a properly
tuned, stand-alone heater unit could be applicable to any field
analytical or preparative method that requires a constant heat
source; e.g., cell lysis or temperature-responsive polymer mediated
concentration. More compelling is the potential of the NINA
heater as the core component of a stand-alone assay kit, capable of
providing a result without external electrical power, a reader
instrument, or any complex ancillaries. Such a device might
include the NINA heater, reaction chambers containing lyophi-
lized reagents, sample metering devices, a readout chamber or
lateral flow strip for visible interrogation, and an LED ‘‘penlight’’
for fluorescence excitation (if required). We envisage versions of
the kit that are fully disposable (for high-value applications
in developed countries such as for home testing and for
first-responder biothreat detection) and partially reusable (primar-
ily for LRS use). Most of the components necessary to create such
a NINA kit already exist. We are currently working to combine
them into a field-ready, instrument- and electricity-free, sample-to-
result, molecular diagnostic test system (Figure S1).
Conclusion
We have demonstrated the ability of an optimized NINA heater
prototype, based on exothermic chemical reactions and EPCM, to
support isothermal NA amplification assays and established its
equivalence to commercially available PCR instruments. The
disposable heater described is a component of an instrument-free
point of care molecular diagnostics system under development.
When combined with other innovations in development that
eliminate power requirements for sample preparation, cold
reagent storage, and readout, the NINA heater will comprise part
of a kit that enables electricity-free NA testing for many important
analytes. Replicate temperature profiles display minimal variation
between runs and far less variation than any similar devices,
highlighting the advantages of including an EPCM in the design.
Versions of the prototype for several isothermal techniques have
been presented, clearly evincing the potential of the NINA heater.
Materials and Methods
Materials
In the NINA heater for LAMP, we used the exothermic
reaction of calcium oxide (CaO, or quicklime; Science Stuff, Inc.,
Austin, TX, USA, Cat # C1450) and water to generate the
necessary heat. To keep the isothermal device within the
temperature band required for LAMP, the reaction chambers
were surrounded with an engineered fat-based compound with a
high specific heat capacity and specific melting range centered
around 65uC (Renewable Alternatives, Inc., Columbia, MO,
USA). While several prototype heater designs have been explored,
the optimized heater uses an off-the-shelf insulated food storage
container (a ‘‘thermos’’) to provide an insulated housing with two
chambers (Figure 5). The bottom chamber contains the exother-
mic reaction, and the upper chamber contains the EPCM and
reaction wells. To facilitate directed heat transfer to the reaction
wells, an aluminum ‘‘honeycomb’’ material (Plascore, Inc.,
Zeeland, MI, USA) was added to the upper chamber prior to
introduction of the EPCM. The machined reaction wells, sized to
closely fit a standard 200-mL PCR tube, are embedded in the
EPCM. Three reaction wells were used for most prototypes (one
for a positive control, one for a negative control, and one for an
unknown specimen); however, the existing prototype could easily
be modified to accept several times this number without significant
loss of performance, based on the available space in the EPCM
and first principles of heat transfer. An inexpensive spring timer
(manufacturer’s suggested retail price [MSRP] <10 US$) with an
audible ‘‘ready’’ indicator was affixed to the lid of the heater unit
for added electricity-free functionality.
LoopampH DNA LAMP kits were purchased from Eiken
Chemical Co. Ltd (Tokyo, Japan, Code No.: LMP206). The Eiken
LoopampH Fluorescence Detection Reagent (Code No.: LMP221),
a Calcein-based reagent that indirectly indicates the progress
of DNA amplification in the LAMP reaction, was used for
fluorescence experiments. LAMP primer sequences for P.
falciparum (Integrated DNA Technologies , Coralville, IA, USA)
were as described by Poon et al.[40] Genomic DNA from P.
falciparum for preparing contrived samples was obtained from the
PATH laboratory specimen collection.
Nucleic Acid Amplification without Electricity
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Germany) or a PE GeneAmpH Thermocycler 9600 (Applied
Biosystems, Carlsbad, CA, USA ) was used as a quantitative
reference instrument for temperature incubation. The ESE-Quant
Tube Scanner also served as a reference for quantitative
fluorescence measurement. A SpectraMax M2 fluorescence plate
reader (Molecular Devices, Sunnyvale, CA, USA) was also used (as
noted in individual experiments). Physitemp IT-23, T-type
thermocouples (Clifton, NJ, USA) and an Omega DaqPRO
5300 Data Recorder (Omega Engineering, Stamford, CT, USA)
were used to monitor temperature.
Methods
Thermocouples were installed in a reaction well (below its
microcentrifuge tube) at the bottom of the chamber containing the
EPCM and in the exothermic reaction chamber for experiments
performed to characterize the temperature profiles of the heaters.
The temperature acquisition rate was 1 Hz. Initial experiments
were focused on refining the dimensions of the heater, optimizing
the quantity and quality of CaO and water, and testing EPCM
formulations—with the goal of minimizing initial pre-heating time
and variability during the specified incubation period. In the
optimized device, 20 gm of CaO and 6.8 mL of water were added
to the bottom chamber and mixed by rotary stirring for five strokes
to initiate the heating and then the components were assembled as
discussed above.
To verify that the device could incubate a LAMP assay, the
Eiken kits were used as per package insert instructions, except
where noted below. Clinically relevant dilutions of genomic DNA
were made in Eiken kit buffer to yield the DNA concentration and
approximate parasite count noted for each experiment. All
dilutions were prepared as single solutions and then aliquoted
across treatment conditions to minimize preparation variation. No
template controls (NTC) were prepared first and immediately
sealed to reduce the possibility of contamination. Mineral oil was
layered on the tops of the samples to minimize evaporation. All
reactions were incubated at 63uC.
Qualitative readout experiments were performed both with and
without the Calcein reagent to determine if turbidimetric readouts
were possible. To compare the performance of the NINA heater to
a reference heater, these experiments were also performed in
parallel with reactions incubated in both the test device and in the
GeneAmpH thermocycler, programmed for a constant incubation
at 63uC.
Quantitative fluorescence experiments were performed in
parallel with reactions incubated in both the test device and in
the ESE-Quant Tube Scanner, programmed for a constant
incubation at 63uC. For NINA incubated reactions, LAMP was
terminated at the time (,36 min.) when the signal from the
parallel reactions on the Tube Scanner began to indicate
detectable amplification to avoid signal saturation in all dilutions.
Termination was accomplished by flash chilling and later
inactivating the reaction by heating at 80uC for 5 minutes. The
fluorescence signals of the NINA incubated samples were then
read on the SpectraMax M2 plate reader with lex=485 nm and
lem=515 nm.
Supporting Information
Figure S1 The workflow of a proposed NA amplification
assay kit. The kit will be an instrument-free, electricity-free
nucleic-acid amplification test that is compatible with whole blood,
is temperature stable and contains contamination. 1) Initiate
NINA heater by installing heater cartridge (a) into insulated
housing (b), add EPCM module (c) and lid (d). 2) Set up for assay
by opening single assay subkit. 3) Sample blood to calibrated line
on collection capillary. 4) Transfer blood and blister contents to
‘‘S’’ tube and prefilled diluent to ‘‘NC’’ and ‘‘PC’’ tubes and mix
all. 5) Amplify. Verify temperature ‘‘ready’’ indication on the
NINA device through transparent view port in the lid, remove the
lid, add the three tubes to the NINA heater, and replace lid.
Incubate 45 minutes. Verify temperature is still in range through
transparent view port (process control). 6) Quench to all three
tubes by pushing cap to burst frangible seal and transfer ,10 mL
diluted quencher to the amplified mixture.
(TIF)
Table S1 Table of references to posters and patents
about the NINA exothermic-heat/EPCM heaters.
(PDF)
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